Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant

Details for Australian Patent Application No. 2011234656 (hide)

Owner Novartis AG

Inventors Ulrich, Peter; Baer, Katja; Imbert, Georges; Hoellinger, Marie-Jose; Riviere, Marie-Emmanuelle; Graf, Ana

Agent Davies Collison Cave

Pub. Number AU-A-2011234656

PCT Pub. Number WO2011/120924

Priority 10158273.2 29.03.10 EP; 61/361,697 06.07.10 US

Filing date 28 March 2011

Wipo publication date 6 October 2011

International Classifications

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/120924 Priority application(s): WO2011/120924

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011234658-Fabric softener active composition

2011234654-Use of novel pan-CDK inhibitors for treating tumors